Theralase Announces Appointment of New Chief Executive Officers
TORONTO, ON / ACCESSWIRE / February 25, 2019 / Theralase Technologies Inc. ("Theralase®" or the "Company") (TSXV: TLT) (OTCQB: TLTFF),...
Uncategorized
Dthera Sciences Announces Exclusivity Period and Option Agreement for its Digital Therapeutic in the Japanese Market
SAN DIEGO, CA / ACCESSWIRE / February 25, 2019 / Dthera™ Sciences (OTCQB: DTHR), a leading digital therapeutic company specialized...
ENDRA Life Sciences to Host Fourth Quarter and Full Year 2018 Results Conference Call on Monday, March 11, 2019 at 4:30 p.m. ET
ANN ARBOR, MICHIGAN / ACCESSWIRE / February 22, 2019 / ENDRA Life Sciences Inc. (''ENDRA'') (NASDAQ: NDRA), a developer of...
Intellipharmaceutics Announces Fiscal Year 2018 Results
TORONTO, ON / ACCESSWIRE / February 22, 2019 / Intellipharmaceutics International Inc. (NASDAQ: IPCI, TSX: IPCI) (''Intellipharmaceutics'' or the ''Company''),...